Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $10.75 million. The enterprise value is -$3.37 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.92 million shares outstanding. The number of shares has increased by 0.91% in one year.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | +0.91% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 23.47% |
| Float | 1.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.02 |
| Forward PS | 3.10 |
| PB Ratio | 0.24 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.53.
| Current Ratio | 3.13 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.92% and return on invested capital (ROIC) is -40.50%.
| Return on Equity (ROE) | -83.92% |
| Return on Assets (ROA) | -34.57% |
| Return on Invested Capital (ROIC) | -40.50% |
| Return on Capital Employed (ROCE) | -87.50% |
| Revenue Per Employee | $69,962 |
| Profits Per Employee | -$1.22M |
| Employee Count | 52 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.59% in the last 52 weeks. The beta is 0.91, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -61.59% |
| 50-Day Moving Average | 6.53 |
| 200-Day Moving Average | 9.70 |
| Relative Strength Index (RSI) | 40.51 |
| Average Volume (20 Days) | 24,051 |
Short Selling Information
The latest short interest is 23,027, so 1.20% of the outstanding shares have been sold short.
| Short Interest | 23,027 |
| Short Previous Month | 430,335 |
| Short % of Shares Out | 1.20% |
| Short % of Float | 1.60% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, BOLT had revenue of $3.64 million and -$63.35 million in losses. Loss per share was -$33.12.
| Revenue | 3.64M |
| Gross Profit | -47.48M |
| Operating Income | -63.26M |
| Pretax Income | -63.03M |
| Net Income | -63.35M |
| EBITDA | -61.54M |
| EBIT | -63.26M |
| Loss Per Share | -$33.12 |
Full Income StatementBalance Sheet
The company has $38.84 million in cash and $24.71 million in debt, giving a net cash position of $14.13 million or $7.37 per share.
| Cash & Cash Equivalents | 38.84M |
| Total Debt | 24.71M |
| Net Cash | 14.13M |
| Net Cash Per Share | $7.37 |
| Equity (Book Value) | 46.81M |
| Book Value Per Share | 24.42 |
| Working Capital | 28.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$57.90 million and capital expenditures -$41,000, giving a free cash flow of -$57.94 million.
| Operating Cash Flow | -57.90M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -57.94M |
| FCF Per Share | -$30.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,738.84% |
| Pretax Margin | -1,741.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.91% |
| Shareholder Yield | -0.91% |
| Earnings Yield | -589.04% |
| FCF Yield | -538.80% |
Analyst Forecast
The average price target for BOLT is $50.00, which is 791.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.00 |
| Price Target Difference | 791.27% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 17.19% |
| EPS Growth Forecast (5Y) | -50.03% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
BOLT has an Altman Z-Score of -8.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.73 |
| Piotroski F-Score | 1 |